Open AccessEfficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: a systematic review and meta-analysis of randomized controlled trials
Author(s) -
Yuqiao Chen,
Xiu Feng,
Chenliang Qi,
Lingfeng Zhou,
Yi Sun,
Zhenhua Gu,
Xiaolong Li
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-1645
Subject(s) - medicine , rivaroxaban , relative risk , randomized controlled trial , meta analysis , cochrane library , myocardial infarction , coronary artery disease , heart failure , confidence interval , atrial fibrillation , warfarin
To evaluate the efficacy and safety of Xa inhibitors in patients with heart failure (HF) and coronary artery disease (CAD) or peripheral artery disease (PAD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom